Back to top
more

Abbott Laboratories (ABT)

(Real Time Quote from BATS)

$115.58 USD

115.58
3,442,429

-2.55 (-2.16%)

Updated Sep 18, 2024 03:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

PAHC vs. ABT: Which Stock Is the Better Value Option?

PAHC vs. ABT: Which Stock Is the Better Value Option?

Abbott (ABT) Rises Higher Than Market: Key Facts

Abbott (ABT) reachead $117.63 at the closing of the latest trading day, reflecting a +1.06% change compared to its last close.

High Tide Inc. (HITI) Surpasses Q3 Earnings and Revenue Estimates

High Tide (HITI) delivered earnings and revenue surprises of 150% and 2.50%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe

RHHBY's Accu-Chek Smartguide will provide several predictive features aimed at enhancing patient safety. However, the device may face tough competition from existing CGM devices.

Urmimala Biswas headshot

Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?

MDT stock breaking above its 200 and 50-day SMAs can be a piece of good news for investors, signaling an uptrend.

Why Abbott (ABT) Outpaced the Stock Market Today

In the latest trading session, Abbott (ABT) closed at $117.11, marking a +0.58% move from the previous day.

Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain?

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who are not on insulin.

Debanjana Dey headshot

Hims & Hers Stock Plunges 32.1% in Three Months: What's Next?

HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Should You Continue to Retain ABT Stock in Your Portfolio Now?

Abbott's robust strength in Core Diagnostics and EPD businesses should continue to benefit in the upcoming quarters.

Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know

In the latest trading session, Abbott (ABT) closed at $114.66, marking a +1.23% move from the previous day.

PAHC vs. ABT: Which Stock Should Value Investors Buy Now?

PAHC vs. ABT: Which Stock Is the Better Value Option?

Abbott (ABT) Stock Moves -0.18%: What You Should Know

Abbott (ABT) closed the most recent trading day at $112.90, moving -0.18% from the previous trading session.

ABT Expands Pure Bliss Line of Products for Advanced Infant Nutrition

Abbott announces the expansion of its Pure Bliss by Similac line of products for infant nutrition with Organic and Organic A2 Milk infant formulas.

DexCom Stock May Gain on Expanded Reach After Stelo's US Launch

DXCM announces that its OTC CGM, Stelo, is now available for purchase in the United States without a prescription.

Abbott's Core Businesses Thrive Despite Macroeconomic Issues

ABT is particularly gaining from the strong adoption of its market leading systems and demand for testing that takes place in a variety of settings.

The Zacks Analyst Blog Eli Lilly, Chevron, Abbott and Bridger Aerospace

Eli Lilly, Chevron, Abbott and Bridger Aerospace are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Eli Lilly, Chevron & Abbott

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Chevron Corporation (CVX) and Abbott Laboratories (ABT), as well as a micro-cap stocks Bridger Aerospace Group Holdings, Inc. (BAER).

Why Is Boston Scientific (BSX) Up 7.2% Since Last Earnings Report?

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abbott (ABT) Gets FDA Approval for Aspirin-Free HeartMate 3 Regimen

Abbott's (ABT) labeling update, exclusively for patients with a HeartMate 3 heart pump, secures the FDA's approval.

Abbott (ABT) Advances While Market Declines: Some Information for Investors

Abbott (ABT) closed the most recent trading day at $112.10, moving +0.64% from the previous trading session.

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?